Log in

OTCMKTS:CVLB - Conversion Labs Stock Price, Forecast & News

$0.14
0.00 (0.00 %)
(As of 12/16/2019 04:53 AM ET)
Today's Range
$0.13
Now: $0.14
$0.14
50-Day Range
$0.13
MA: $0.16
$0.19
52-Week Range
$0.08
Now: $0.14
$0.20
Volume26,800 shs
Average Volume88,233 shs
Market Capitalization$7.43 million
P/E RatioN/A
Dividend YieldN/A
Beta0.98
Conversion Labs, Inc., an Internet-based direct response marketing company, licenses, acquires, creates, and sells various products to consumers worldwide. Its products include Shapiro MD, a shampoo, conditioner, and leave-in foamer for thicker fuller hair; iNR Wellness MD, a nutritional supplement for immune support; and PDF Simpli, a PDF conversion software. The company sells its products through technology infrastructure and relationships with agencies, third party marketers, and online advertising platforms, as well as through its Websites inrwellness.com and shapiromd.com. The company was formerly known as Immudyne, Inc. and changed its name to Conversion Labs, Inc. in June 2018. Conversion Labs, Inc. was incorporated in 1987 and is based in New York, New York.

Industry, Sector and Symbol

Industry Miscellaneous manufacturing industries
Sub-IndustryN/A
SectorConsumer Staples
Current SymbolOTCMKTS:CVLB
CUSIPN/A
CIKN/A
Phone866-351-5907

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$8.32 million
Book Value$0.02 per share

Profitability

Net Income$-1,240,000.00

Miscellaneous

Employees16
Market Cap$7.43 million
Next Earnings Date4/3/2020 (Estimated)
OptionableNot Optionable

Receive CVLB News and Ratings via Email

Sign-up to receive the latest news and ratings for CVLB and its competitors with MarketBeat's FREE daily newsletter.


Conversion Labs (OTCMKTS:CVLB) Frequently Asked Questions

What is Conversion Labs' stock symbol?

Conversion Labs trades on the OTCMKTS under the ticker symbol "CVLB."

How were Conversion Labs' earnings last quarter?

Conversion Labs Inc (OTCMKTS:CVLB) issued its quarterly earnings data on Thursday, November, 14th. The company reported ($0.02) earnings per share for the quarter. The company had revenue of $3.13 million for the quarter. Conversion Labs had a negative net margin of 23.63% and a negative return on equity of 674.88%. View Conversion Labs' Earnings History.

When is Conversion Labs' next earnings date?

Conversion Labs is scheduled to release their next quarterly earnings announcement on Friday, April 3rd 2020. View Earnings Estimates for Conversion Labs.

Has Conversion Labs been receiving favorable news coverage?

News headlines about CVLB stock have been trending negative this week, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Conversion Labs earned a coverage optimism score of -2.8 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Conversion Labs.

Who are some of Conversion Labs' key competitors?

What other stocks do shareholders of Conversion Labs own?

Who are Conversion Labs' key executives?

Conversion Labs' management team includes the folowing people:
  • Mr. Justin Schreiber, CEO, Pres & Director (Age 36)
  • Mr. Stefan Galluppi, COO, Chief Technology Officer & Director (Age 32)
  • Dr. Joseph V. DiTrolio, Chief Medical Officer of North America & Director (Age 68)
  • Mr. Robert Kalkstein, Advisor to the CEO (Age 37)
  • Mr. Sean Fitzpatrick, Chief Acquisition Officer (Age 36)

How do I buy shares of Conversion Labs?

Shares of CVLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Conversion Labs' stock price today?

One share of CVLB stock can currently be purchased for approximately $0.14.

How big of a company is Conversion Labs?

Conversion Labs has a market capitalization of $7.43 million and generates $8.32 million in revenue each year. Conversion Labs employs 16 workers across the globe.View Additional Information About Conversion Labs.

What is Conversion Labs' official website?

The official website for Conversion Labs is http://www.conversionlabs.com/.

How can I contact Conversion Labs?

Conversion Labs' mailing address is 800 THIRD AVENUE SUITE 2800, NEW YORK NY, 10022. The company can be reached via phone at 866-351-5907 or via email at ir.conversionlabs.com.


MarketBeat Community Rating for Conversion Labs (OTCMKTS CVLB)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  95 (Vote Outperform)
Underperform Votes:  99 (Vote Underperform)
Total Votes:  194
MarketBeat's community ratings are surveys of what our community members think about Conversion Labs and other stocks. Vote "Outperform" if you believe CVLB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CVLB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/16/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel